BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19144636)

  • 1. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D.
    Zang Y; Yu LF; Nan FJ; Feng LY; Li J
    J Biol Chem; 2009 Mar; 284(10):6175-84. PubMed ID: 19144636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase.
    Zang Y; Yu LF; Pang T; Fang LP; Feng X; Wen TQ; Nan FJ; Feng LY; Li J
    J Biol Chem; 2008 Mar; 283(10):6201-8. PubMed ID: 18077446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AMP-activated protein kinase inhibits the proliferation of human endothelial cells.
    Peyton KJ; Liu XM; Yu Y; Yates B; Durante W
    J Pharmacol Exp Ther; 2012 Sep; 342(3):827-34. PubMed ID: 22700432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
    Theodoropoulou S; Kolovou PE; Morizane Y; Kayama M; Nicolaou F; Miller JW; Gragoudas E; Ksander BR; Vavvas DG
    FASEB J; 2010 Aug; 24(8):2620-30. PubMed ID: 20371623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
    Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
    Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
    Al-Moujahed A; Nicolaou F; Brodowska K; Papakostas TD; Marmalidou A; Ksander BR; Miller JW; Gragoudas E; Vavvas DG
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4175-85. PubMed ID: 24781943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
    Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
    Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
    Rattan R; Giri S; Singh AK; Singh I
    J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosis.
    Theodoropoulou S; Brodowska K; Kayama M; Morizane Y; Miller JW; Gragoudas ES; Vavvas DG
    PLoS One; 2013; 8(1):e52852. PubMed ID: 23300996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
    Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
    J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
    Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
    Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
    Zhuge J
    Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression.
    Kim JE; Kim YW; Lee IK; Kim JY; Kang YJ; Park SY
    J Pharmacol Sci; 2008 Mar; 106(3):394-403. PubMed ID: 18360094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation.
    Jacobs RL; Lingrell S; Dyck JRB; Vance DE
    J Biol Chem; 2007 Feb; 282(7):4516-4523. PubMed ID: 17179149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
    Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
    J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
    Suwa M; Nakano H; Radak Z; Kumagai S
    Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures.
    Łabuzek K; Liber S; Gabryel B; Okopień B
    Neurotoxicology; 2010 Jan; 31(1):134-46. PubMed ID: 19853624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.